Acutus Medical, Inc.
AFIB
$0.042
$0.000.00%
| Weiss Ratings | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.35 | |||
| Price History | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -8.50% | |||
| 30-Day Total Return | -39.74% | |||
| 60-Day Total Return | -35.38% | |||
| 90-Day Total Return | -72.90% | |||
| Year to Date Total Return | -7.49% | |||
| 1-Year Total Return | -76.55% | |||
| 2-Year Total Return | -95.28% | |||
| 3-Year Total Return | -97.50% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -84.44% | |||
| 52-Week Low % Change | 67.33% | |||
| Price | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.27 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Jul 12, 2024 | |||
| 52-Week High Price (Date) | Mar 18, 2024 | |||
| Valuation | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.26M | |||
| Enterprise Value | 24.44M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.43 | |||
| Earnings Per Share Growth | 83.80% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.08 | |||
| Price/Book (Q) | -0.12 | |||
| Enterprise Value/Revenue (TTM) | 1.59 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -1.84 | |||
| Enterprise Value/EBIT | -1.84 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 29.80M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 442 232 6080 | |||
| Address | 2210 Faraday Avenue Carlsbad, CA 92008 | |||
| Website | www.acutusmedical.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -86.50% | |||
| Profit Margin | -272.71% | |||
| Management Effectiveness | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.21% | |||
| Return on Equity | -- | |||
| Income Statement | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 15.37M | |||
| Total Revenue (TTM) | 15.37M | |||
| Revenue Per Share | $0.52 | |||
| Gross Profit (TTM) | -119.00K | |||
| EBITDA (TTM) | -13.25M | |||
| EBIT (TTM) | -13.29M | |||
| Net Income (TTM) | -41.91M | |||
| Net Income Avl. to Common (TTM) | -41.91M | |||
| Total Revenue Growth (Q YOY) | 155.63% | |||
| Earnings Growth (Q YOY) | 57.46% | |||
| EPS Diluted (TTM) | -1.43 | |||
| EPS Diluted Growth (Q YOY) | 58.39% | |||
| Balance Sheet | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 12.60M | |||
| Cash Per Share (Q) | $0.42 | |||
| Total Current Assets (Q) | 27.16M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -10.30M | |||
| Current Ratio (Q) | 1.852 | |||
| Book Value Per Share (Q) | -$0.34 | |||
| Total Assets (Q) | 32.17M | |||
| Total Current Liabilities (Q) | 14.67M | |||
| Total Debt (Q) | 35.78M | |||
| Total Liabilities (Q) | 42.47M | |||
| Total Common Equity (Q) | -10.30M | |||
| Cash Flow | AFIB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 27.90M | |||
| Cash from Financing (TTM) | -3.16M | |||
| Net Change in Cash (TTM) | -18.52M | |||
| Levered Free Cash Flow (TTM) | 4.71M | |||
| Cash from Operations (TTM) | -45.62M | |||
